Josef Coresh chercheur
Coresh, Josef
VIAF ID: 309794064 (Personal)
Permalink: http://viaf.org/viaf/309794064
Preferred Forms
- 100 1 _ ‡a Coresh, Josef
- 100 1 _ ‡a Coresh, Josef
- 100 0 _ ‡a Josef Coresh ‡c chercheur
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Epigenome-wide association studies identify DNA methylation associated with kidney function | |
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease | |
Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study | |
Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies | |
Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts | |
Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation | |
Remodeling of carotid arteries detected with MR imaging: atherosclerosis risk in communities carotid MRI study | |
Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes | |
Reverse epidemiology: a confusing, confounding, and inaccurate term | |
Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study | |
Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland | |
Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort study | |
Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities | |
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study | |
Risk of ESRD and Mortality Associated With Change in Filtration Markers | |
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities | |
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III) | |
Serum fibroblast growth factor-23 is associated with incident kidney disease | |
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients | |
Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease | |
Serum metabolites are associated with all-cause mortality in chronic kidney disease | |
Serum metabolomic profiling and incident CKD among African Americans | |
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. | |
Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study | |
Short-term change in kidney function and risk of end-stage renal disease. | |
Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults. | |
Short-term variability in measures of glycemia and implications for the classification of diabetes. | |
SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study | |
Socioeconomic measures and CKD in the United States and The Netherlands | |
Socioeconomic Status and Incidence of Hospitalization With Lower-Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study | |
SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function | |
Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study | |
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study | |
Spousal Influence on Physical Activity in Middle-Aged and Older Adults: The ARIC Study | |
sRAGE and risk of diabetes, cardiovascular disease, and death | |
Statin use and sepsis events [corrected] in patients with chronic kidney disease | |
Stroke incidence and mortality trends in US communities, 1987 to 2011. | |
Subclinical atherosclerosis measures for cardiovascular prediction in CKD | |
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels | |
TCF7L2 variants associate with CKD progression and renal function in population-based cohorts | |
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality | |
Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population | |
Temporal Trends in Hospitalization for Acute Decompensated Heart Failure in the United States, 1998-2011. | |
Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study | |
Total Short-term Variability in Biomarkers of Hyperglycemia in Older Adults | |
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study | |
Transition models for change-point estimation in logistic regression | |
Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study | |
Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. | |
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates | |
Trends in the timing of pre-emptive kidney transplantation | |
Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients | |
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study | |
Update on the Burden of CKD. | |
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease | |
Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression | |
Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease | |
Uromodulin levels associate with a common UMOD variant and risk for incident CKD. | |
Use of wrapper algorithms coupled with a random forests classifier for variable selection in large-scale genomic association studies | |
Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate | |
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | |
Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study. | |
Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease | |
Variation and temporal trends in the use of diagnostic testing during hospitalization for acute myocardial infarction by age, gender, race, and geography (the Atherosclerosis Risk In Communities Study) | |
Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study | |
Within-person variability in kidney measures |